Incannex Healthcare Inc. (IXHL)
NASDAQ: IXHL · Real-Time Price · USD
3.640
-0.050 (-1.36%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Incannex Healthcare Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 74.45 | 15.04 | 5.86 | 22.12 | 25.84 | 6.84 |
Cash & Short-Term Investments | 74.45 | 15.04 | 5.86 | 22.12 | 25.84 | 6.84 |
Cash Growth | 1009.37% | 156.73% | -73.52% | -14.39% | 277.73% | 174.95% |
Other Receivables | 5.46 | 4.63 | 10.02 | 0.19 | 0.2 | 0.13 |
Receivables | 5.46 | 4.63 | 10.02 | 0.19 | 0.2 | 0.13 |
Prepaid Expenses | 0.18 | 0.3 | 0.33 | 0.69 | 0.04 | 0.03 |
Other Current Assets | - | - | - | - | 0.02 | - |
Total Current Assets | 80.1 | 19.96 | 16.2 | 23 | 26.1 | 6.99 |
Property, Plant & Equipment | 0.16 | 0.49 | 0.85 | 0.79 | - | - |
Total Assets | 80.28 | 20.45 | 17.05 | 23.78 | 26.1 | 6.99 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 1.6 | 6.07 | 0.53 | 1.75 | 0.9 | 0.17 |
Accrued Expenses | 0.22 | 0.7 | 4.85 | 0.69 | 0.49 | 0.39 |
Current Portion of Leases | 0.07 | 0.18 | 0.16 | 0.11 | - | - |
Current Unearned Revenue | 0.03 | 0.03 | 0.09 | - | - | - |
Total Current Liabilities | 1.93 | 6.98 | 5.62 | 2.55 | 1.39 | 0.57 |
Long-Term Leases | 0.04 | 0.07 | 0.21 | 0.41 | - | - |
Total Liabilities | 5.05 | 7.06 | 5.83 | 2.96 | 1.39 | 0.57 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 0.04 | 0.02 | 0 | 0 | 59.66 | 34.38 |
Additional Paid-In Capital | 253.22 | 174.05 | 125.22 | 116.29 | 5.57 | 4.96 |
Retained Earnings | -174.37 | -157.56 | -110.67 | -92.21 | -40.51 | -32.91 |
Comprehensive Income & Other | -3.66 | -3.12 | -3.33 | -3.26 | - | - |
Shareholders' Equity | 75.23 | 13.39 | 11.22 | 20.83 | 24.71 | 6.43 |
Total Liabilities & Equity | 80.28 | 20.45 | 17.05 | 23.78 | 26.1 | 6.99 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 0.11 | 0.26 | 0.37 | 0.52 | - | - |
Net Cash (Debt) | 74.34 | 14.78 | 5.49 | 21.6 | 25.84 | 6.84 |
Net Cash Growth | 1379.62% | 169.48% | -74.61% | -16.41% | 277.73% | 174.95% |
Net Cash Per Share | 8.01 | 12.87 | 10.18 | 42.12 | 2.60 | 0.84 |
Filing Date Shares Outstanding | 11.96 | 11.59 | 0.59 | 13.19 | 11.43 | 8.98 |
Total Common Shares Outstanding | 13.68 | 6.48 | 0.59 | 13.23 | 10.77 | 8.9 |
Working Capital | 78.17 | 12.98 | 10.58 | 20.45 | 24.71 | 6.43 |
Book Value Per Share | 5.50 | 2.07 | 19.07 | 1.57 | 2.29 | 0.72 |
Tangible Book Value | 75.23 | 13.39 | 11.22 | 20.83 | 24.71 | 6.43 |
Tangible Book Value Per Share | 5.50 | 2.07 | 19.07 | 1.57 | 2.29 | 0.72 |
Machinery | 0.57 | 0.5 | 0.6 | 0.16 | - | - |
Construction In Progress | - | - | - | 0.16 | - | - |